Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.04 (-4.84%)
Close on Nov 12, 2026Market cap $45.82MP/E –Yield 0.00%
Pliant Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Pliant Therapeutics's operating margin for the twelve months ending Mar 31, 2024 was -78404.0%. For fiscal 2023 it was -11654.7%, against -1313.4% the year before. The highest annual figure on record is -2.2% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -11654.7% | −10341.4 |
| FY2022 | Dec 31, 2022 | -1313.4% | −25.3 |
| FY2021 | Dec 31, 2021 | -1288.1% | −1188.5 |
| FY2020 | Dec 31, 2020 | -99.6% | −97.4 |
| FY2019 | Dec 31, 2019 | -2.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | -19083.9% | −18489.7 |
| Q1 FY2023 | Mar 31, 2023 | -3160.3% | −901.6 |
| Q4 FY2022 | Dec 31, 2022 | -1903.3% | −672.7 |
| Q3 FY2022 | Sep 30, 2022 | -2155.7% | −471.6 |
| Q2 FY2022 | Jun 30, 2022 | -594.1% | +686.1 |
| Q1 FY2022 | Mar 31, 2022 | -2258.7% | −1204.5 |
| Q4 FY2021 | Dec 31, 2021 | -1230.6% | −804.7 |
| Q3 FY2021 | Sep 30, 2021 | -1684.0% | −1337.9 |
| Q2 FY2021 | Jun 30, 2021 | -1280.3% | −808.7 |
| Q1 FY2021 | Mar 31, 2021 | -1054.2% | −1092.3 |
| Q4 FY2020 | Dec 31, 2020 | -425.9% | – |
| Q3 FY2020 | Sep 30, 2020 | -346.1% | – |
| Q2 FY2020 | Jun 30, 2020 | -471.6% | – |
| Q1 FY2020 | Mar 31, 2020 | 38.0% | – |
See a number that looks wrong?